Amylyx Pharmaceuticals Inc. (AMLX) NASDAQ
$1.83 0.01 (0.55%)
Market Cap: $123.77M
As of 05/16/24 03:59 PM EDT. Market closed.
Amylyx Pharmaceuticals Inc. (AMLX)
NASDAQ
$1.83
0.01 (0.55%)
Market Cap: $123.77M
As of 05/16/24 03:59 PM EDT. Market closed.
Add to Portfolio
Amylyx Pharmaceuticals, Inc is a biopharmaceutical company headquartered in Cambridge, Massachusetts. Amylyx is best known for AMX0035, an experimental therapy for amyotrophic lateral ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full Time Employees
259
URL
Address
.
PRICE CHART FOR AMYLYX PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.83
Previous Close
$1.82
Days Range
$1.82 - $1.94
52 week range
$1.70 - $27.99
Volume
776,610
Avg. Volume (30 days)
1,892,997
Market Cap
$123.77M
Dividend Yield
-
P/E
(1.74)
Shares Outstanding
68,005,749
Open
$1.83
Previous Close
$1.82
Days Range
$1.82 - $1.94
52 week range
$1.70 - $27.99
Volume
776,610
Avg. Volume (30 days)
1,892,997
Market Cap
$123.77M
Dividend Yield
-
P/E
(1.74)
Shares Outstanding
68,005,749
FINANCIAL STATEMENTS FOR AMYLYX PHARMACEUTICALS INC
LOADING...
INSIDER TRANSACTIONS FOR AMYLYX PHARMACEUTICALS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Cohen Joshua B | Co-Chief Executive Officer | Mar 05, 2024 | Sale | $18.73 | 4,135 | 77,440 | 3,023,002 | Mar 07, 2024, 04:05 PM |
Klee Justin B. | Co-Chief Executive Officer | Mar 05, 2024 | Sale | $18.73 | 4,135 | 77,440 | 2,959,308 | Mar 07, 2024, 04:05 PM |
FRATES JAMES M | Chief Financial Officer | Mar 05, 2024 | Sale | $18.73 | 1,792 | 33,560 | 134,784 | Mar 07, 2024, 04:05 PM |
Mazzariello Gina | Chief Legal Officer | Mar 05, 2024 | Sale | $18.73 | 1,540 | 28,841 | 81,372 | Mar 07, 2024, 04:05 PM |
Mazzariello Gina | Chief Legal Officer | Feb 23, 2024 | Sale | $18.76 | 2,838 | 53,231 | 46,245 | Feb 27, 2024, 05:59 PM |
Klee Justin B. | Co-Chief Executive Officer | Jan 09, 2024 | Sale | $16.33 | 5,841 | 95,372 | 2,836,776 | Jan 11, 2024, 05:11 PM |
FRATES JAMES M | Chief Financial Officer | Jan 09, 2024 | Sale | $16.33 | 2,716 | 44,347 | 112,035 | Jan 11, 2024, 05:11 PM |
Cohen Joshua B | Co-Chief Executive Officer | Jan 09, 2024 | Sale | $16.33 | 5,841 | 95,372 | 2,900,470 | Jan 11, 2024, 05:10 PM |
Yeramian Patrick D | Chief Medical Officer | Jan 09, 2024 | Sale | $16.33 | 2,812 | 45,915 | 205,605 | Jan 11, 2024, 05:04 PM |
Olinger Margaret | Chief Commercial Officer | Dec 27, 2023 | Option Exercise | $0.37 | 25,000 | 9,250 | 276,108 | Dec 29, 2023, 04:07 PM |
Firestone Karen | Director | Dec 15, 2023 | Buy | $14.97 | 4,000 | 59,880 | 5,000 | Dec 19, 2023, 04:37 PM |
Cohen Joshua B | Co-Chief Executive Officer | Nov 16, 2023 | Option Exercise | $1.57 | 63,694 | 100,000 | 2,906,311 | Nov 20, 2023, 08:20 PM |
FRATES JAMES M | Chief Financial Officer | Aug 23, 2023 | Option Exercise | $6.88 | 18,165 | 124,975 | 106,341 | Aug 24, 2023, 04:15 PM |
Mazzariello Gina | Chief Legal Officer | Aug 15, 2023 | Sale | $20.88 | 6,164 | 128,686 | 49,083 | Aug 17, 2023, 04:35 PM |
Olinger Margaret | Chief Commercial Officer | Jul 12, 2023 | Option Exercise | $0.37 | 20,000 | 7,400 | 251,108 | Jul 14, 2023, 04:20 PM |
FRATES JAMES M | Chief Financial Officer | May 16, 2023 | Option Exercise | $6.88 | 32,500 | 223,600 | 88,176 | May 18, 2023, 08:54 PM |
FRATES JAMES M | Chief Financial Officer | May 16, 2023 | Sale | $26.94 | 32,500 | 875,451 | 56,176 | May 18, 2023, 08:54 PM |
Yeramian Patrick D | Chief Medical Officer | May 15, 2023 | Option Exercise | $5.68 | 11,965 | 67,991 | 220,382 | May 17, 2023, 04:58 PM |
Yeramian Patrick D | Chief Medical Officer | May 15, 2023 | Sale | $29.03 | 11,965 | 347,358 | 208,417 | May 17, 2023, 04:58 PM |
Yeramian Patrick D | Chief Medical Officer | Apr 17, 2023 | Option Exercise | $0.99 | 49,579 | 49,058 | 257,996 | Apr 19, 2023, 07:45 PM |
Yeramian Patrick D | Chief Medical Officer | Apr 17, 2023 | Sale | $30.54 | 49,579 | 1,513,942 | 208,717 | Apr 19, 2023, 07:45 PM |
Morningside Venture Investments Ltd | 10% Owner | Mar 29, 2023 | Sale | $30.45 | 29,048 | 884,512 | 6,997,302 | Mar 31, 2023, 04:05 PM |
Morningside Venture Investments Ltd | 10% Owner | Mar 27, 2023 | Sale | $30.50 | 60,964 | 1,859,561 | 7,154,350 | Mar 29, 2023, 04:05 PM |
Morningside Venture Investments Ltd | 10% Owner | Mar 28, 2023 | Sale | $30.37 | 100,000 | 3,037,000 | 7,026,350 | Mar 29, 2023, 04:05 PM |
FRATES JAMES M | Chief Financial Officer | Mar 16, 2023 | Option Exercise | $6.88 | 32,500 | 223,600 | 66,509 | Mar 24, 2023, 06:48 PM |
FRATES JAMES M | Chief Financial Officer | Mar 16, 2023 | Sale | $31.89 | 32,500 | 1,036,459 | 35,713 | Mar 24, 2023, 06:48 PM |
Yeramian Patrick D | Chief Medical Officer | Mar 16, 2023 | Option Exercise | $2.57 | 49,578 | 127,262 | 253,877 | Mar 24, 2023, 06:45 PM |
Yeramian Patrick D | Chief Medical Officer | Mar 16, 2023 | Sale | $31.87 | 54,627 | 1,741,200 | 201,666 | Mar 24, 2023, 06:45 PM |
Morningside Venture Investments Ltd | 10% Owner | Mar 21, 2023 | Sale | $31.91 | 63,448 | 2,024,494 | 7,216,121 | Mar 23, 2023, 04:05 PM |
Klee Justin B. | Co-Chief Executive Officer | Mar 16, 2023 | Sale | $31.86 | 100,000 | 3,186,236 | 2,796,062 | Mar 20, 2023, 08:31 PM |
MILNE GEORGE M JR | Director | Mar 16, 2023 | Sale | $31.89 | 35,000 | 1,116,072 | 863,937 | Mar 20, 2023, 08:25 PM |
Yeramian Patrick D | Chief Medical Officer | Mar 16, 2023 | Sale | $31.87 | 54,627 | 1,741,200 | 152,088 | Mar 20, 2023, 08:25 PM |
Firestone Karen | Director | Mar 16, 2023 | Buy | $31.99 | 1,000 | 31,990 | 1,000 | Mar 20, 2023, 08:22 PM |
Cohen Joshua B | Co-Chief Executive Officer | Mar 16, 2023 | Sale | $31.86 | 100,000 | 3,186,336 | 2,796,541 | Mar 20, 2023, 08:21 PM |
FRATES JAMES M | Chief Financial Officer | Mar 16, 2023 | Sale | $31.89 | 32,500 | 1,036,459 | 3,213 | Mar 20, 2023, 08:18 PM |
Morningside Venture Investments Ltd | 10% Owner | Mar 16, 2023 | Sale | $32.55 | 9,122 | 296,921 | 7,250,762 | Mar 17, 2023, 04:05 PM |
Morningside Venture Investments Ltd | 10% Owner | Mar 15, 2023 | Sale | $33.27 | 150,000 | 4,990,997 | 7,300,950 | Mar 16, 2023, 04:11 PM |
Morningside Venture Investments Ltd | 10% Owner | Mar 14, 2023 | Sale | $34.54 | 70,714 | 2,442,462 | 7,409,884 | Mar 16, 2023, 04:11 PM |
Morningside Venture Investments Ltd | 10% Owner | Mar 02, 2023 | Sale | $33.75 | 50,000 | 1,687,500 | 7,480,598 | Mar 06, 2023, 09:10 AM |
Mazzariello Gina | Chief Legal Officer | Feb 24, 2023 | Sale | $34.49 | 3,586 | 123,672 | 37,414 | Feb 28, 2023, 04:42 PM |
Morningside Venture Investments Ltd | 10% Owner | Feb 22, 2023 | Sale | $34.73 | 50,000 | 1,736,352 | 7,532,710 | Feb 28, 2023, 04:06 PM |
Morningside Venture Investments Ltd | 10% Owner | Feb 22, 2023 | Sale | $36.00 | 50,000 | 1,799,836 | 7,640,682 | Feb 24, 2023, 04:13 PM |
Morningside Venture Investments Ltd | 10% Owner | Feb 23, 2023 | Sale | $35.57 | 50,000 | 1,778,267 | 7,581,709 | Feb 24, 2023, 04:13 PM |
Yeramian Patrick D | Chief Medical Officer | Jan 06, 2023 | Sale | $36.30 | 2,034 | 73,831 | 204,928 | Jan 10, 2023, 07:22 PM |
Cohen Joshua B | Co-Chief Executive Officer | Jan 06, 2023 | Sale | $36.30 | 5,968 | 216,629 | 2,894,463 | Jan 10, 2023, 07:20 PM |
FRATES JAMES M | Chief Financial Officer | Jan 06, 2023 | Sale | $36.30 | 2,658 | 96,481 | 34,831 | Jan 10, 2023, 07:20 PM |
Olinger Margaret | Chief Commercial Officer | Jan 06, 2023 | Sale | $36.30 | 2,403 | 87,225 | 215,098 | Jan 10, 2023, 07:19 PM |
Klee Justin B. | Co-Chief Executive Officer | Jan 06, 2023 | Sale | $36.30 | 5,968 | 216,629 | 2,894,463 | Jan 10, 2023, 07:12 PM |
FRATES JAMES M | Chief Financial Officer | Dec 30, 2022 | Option Exercise | $6.88 | 5,000 | 34,400 | 36,667 | Jan 04, 2023, 09:33 PM |
VIKING GLOBAL INVESTORS LP | 10% Owner | Sep 09, 2022 | Sale | $30.23 | 700,000 | 21,159,753 | 4,082,713 | Sep 09, 2022, 09:48 PM |
VIKING GLOBAL INVESTORS LP | 10% Owner | Sep 08, 2022 | Sale | $29.37 | 700,000 | 20,559,886 | 4,789,821 | Sep 09, 2022, 09:48 PM |
ALS Invest 1 B.V. | 10% Owner | Jul 06, 2022 | Sale | $20.70 | 60,609 | 1,254,642 | 5,937,577 | Jul 08, 2022, 06:44 PM |
Klee Justin B. | Co-Chief Executive Officer | May 05, 2022 | Option Exercise | $0.37 | 334,520 | 123,772 | 2,898,585 | May 06, 2022, 04:05 PM |
Cohen Joshua B | Co-Chief Executive Officer | May 05, 2022 | Option Exercise | $0.37 | 334,520 | 123,772 | 2,898,585 | May 06, 2022, 04:05 PM |
Morningside Venture Investments Ltd | 10% Owner | Jan 11, 2022 | Buy | $19.00 | 263,158 | 5,000,002 | 10,678,808 | Mar 17, 2022, 05:14 PM |
Morningside Venture Investments Ltd | 10% Owner | Jan 11, 2022 | Buy | $19.00 | 263,158 | 5,000,002 | 10,678,808 | Jan 25, 2022, 04:46 PM |
VIKING GLOBAL INVESTORS LP | 10% Owner | Jan 11, 2022 | Buy | $19.00 | 2,300,000 | 43,700,000 | 2,300,000 | Jan 13, 2022, 09:05 PM |
FONTEYNE PAUL R. | Director | Jan 06, 2022 | Buy | $19.00 | 3,947 | 74,993 | 3,947 | Jan 10, 2022, 08:37 PM |
Cheng Isaac | Director | Jan 06, 2022 | Buy | $19.00 | 6,578 | 124,982 | 6,578 | Jan 10, 2022, 08:35 PM |
MILNE GEORGE M JR | Director | Jan 06, 2022 | Buy | $19.00 | 26,315 | 499,985 | 221,396 | Jan 10, 2022, 08:34 PM |
Olinger Margaret | Chief Commercial Officer | Jan 06, 2022 | Buy | $19.00 | 6,842 | 129,998 | 216,758 | Jan 10, 2022, 08:30 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Cohen Joshua B | Co-Chief Executive Officer | 03/05/2024 | 77,440 |
Klee Justin B. | Co-Chief Executive Officer | 03/05/2024 | 77,440 |
FRATES JAMES M | Chief Financial Officer | 03/05/2024 | 33,560 |
Mazzariello Gina | Chief Legal Officer | 03/05/2024 | 28,841 |
Mazzariello Gina | Chief Legal Officer | 02/23/2024 | 53,231 |
Klee Justin B. | Co-Chief Executive Officer | 01/09/2024 | 95,372 |
FRATES JAMES M | Chief Financial Officer | 01/09/2024 | 44,347 |
Cohen Joshua B | Co-Chief Executive Officer | 01/09/2024 | 95,372 |
Yeramian Patrick D | Chief Medical Officer | 01/09/2024 | 45,915 |
Olinger Margaret | Chief Commercial Officer | 12/27/2023 | 9,250 |
Firestone Karen | Director | 12/15/2023 | 59,880 |
Cohen Joshua B | Co-Chief Executive Officer | 11/16/2023 | 100,000 |
FRATES JAMES M | Chief Financial Officer | 08/23/2023 | 124,975 |
Mazzariello Gina | Chief Legal Officer | 08/15/2023 | 128,686 |
Olinger Margaret | Chief Commercial Officer | 07/12/2023 | 7,400 |
FRATES JAMES M | Chief Financial Officer | 05/16/2023 | 223,600 |
FRATES JAMES M | Chief Financial Officer | 05/16/2023 | 875,451 |
Yeramian Patrick D | Chief Medical Officer | 05/15/2023 | 67,991 |
Yeramian Patrick D | Chief Medical Officer | 05/15/2023 | 347,358 |
Yeramian Patrick D | Chief Medical Officer | 04/17/2023 | 49,058 |
Yeramian Patrick D | Chief Medical Officer | 04/17/2023 | 1,513,942 |
Morningside Venture Investments Ltd | 10% Owner | 03/29/2023 | 884,512 |
Morningside Venture Investments Ltd | 10% Owner | 03/27/2023 | 1,859,561 |
Morningside Venture Investments Ltd | 10% Owner | 03/28/2023 | 3,037,000 |
FRATES JAMES M | Chief Financial Officer | 03/16/2023 | 223,600 |
FRATES JAMES M | Chief Financial Officer | 03/16/2023 | 1,036,459 |
Yeramian Patrick D | Chief Medical Officer | 03/16/2023 | 127,262 |
Yeramian Patrick D | Chief Medical Officer | 03/16/2023 | 1,741,200 |
Morningside Venture Investments Ltd | 10% Owner | 03/21/2023 | 2,024,494 |
Klee Justin B. | Co-Chief Executive Officer | 03/16/2023 | 3,186,236 |
MILNE GEORGE M JR | Director | 03/16/2023 | 1,116,072 |
Yeramian Patrick D | Chief Medical Officer | 03/16/2023 | 1,741,200 |
Firestone Karen | Director | 03/16/2023 | 31,990 |
Cohen Joshua B | Co-Chief Executive Officer | 03/16/2023 | 3,186,336 |
FRATES JAMES M | Chief Financial Officer | 03/16/2023 | 1,036,459 |
Morningside Venture Investments Ltd | 10% Owner | 03/16/2023 | 296,921 |
Morningside Venture Investments Ltd | 10% Owner | 03/15/2023 | 4,990,997 |
Morningside Venture Investments Ltd | 10% Owner | 03/14/2023 | 2,442,462 |
Morningside Venture Investments Ltd | 10% Owner | 03/02/2023 | 1,687,500 |
Mazzariello Gina | Chief Legal Officer | 02/24/2023 | 123,672 |
Morningside Venture Investments Ltd | 10% Owner | 02/22/2023 | 1,736,352 |
Morningside Venture Investments Ltd | 10% Owner | 02/22/2023 | 1,799,836 |
Morningside Venture Investments Ltd | 10% Owner | 02/23/2023 | 1,778,267 |
Yeramian Patrick D | Chief Medical Officer | 01/06/2023 | 73,831 |
Cohen Joshua B | Co-Chief Executive Officer | 01/06/2023 | 216,629 |
FRATES JAMES M | Chief Financial Officer | 01/06/2023 | 96,481 |
Olinger Margaret | Chief Commercial Officer | 01/06/2023 | 87,225 |
Klee Justin B. | Co-Chief Executive Officer | 01/06/2023 | 216,629 |
FRATES JAMES M | Chief Financial Officer | 12/30/2022 | 34,400 |
VIKING GLOBAL INVESTORS LP | 10% Owner | 09/09/2022 | 21,159,753 |
VIKING GLOBAL INVESTORS LP | 10% Owner | 09/08/2022 | 20,559,886 |
ALS Invest 1 B.V. | 10% Owner | 07/06/2022 | 1,254,642 |
Klee Justin B. | Co-Chief Executive Officer | 05/05/2022 | 123,772 |
Cohen Joshua B | Co-Chief Executive Officer | 05/05/2022 | 123,772 |
Morningside Venture Investments Ltd | 10% Owner | 01/11/2022 | 5,000,002 |
Morningside Venture Investments Ltd | 10% Owner | 01/11/2022 | 5,000,002 |
VIKING GLOBAL INVESTORS LP | 10% Owner | 01/11/2022 | 43,700,000 |
FONTEYNE PAUL R. | Director | 01/06/2022 | 74,993 |
Cheng Isaac | Director | 01/06/2022 | 124,982 |
MILNE GEORGE M JR | Director | 01/06/2022 | 499,985 |
Olinger Margaret | Chief Commercial Officer | 01/06/2022 | 129,998 |
Load More Insider Transactions
FUNDS WITH A POSITION IN AMYLYX PHARMACEUTICALS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 4,474,722 | 0.0003% | 11.8% | Other |
VIKING GLOBAL INVESTORS LP | 2,962,555 | 0.16% | Exited | Growth At A Reasonable Price |
FARALLON CAPITAL MANAGEMENT LLC | 1,150,221 | 0.01% | New | Event Driven, Value |
GEODE CAPITAL MANAGEMENT, LLC | 1,066,245 | 0.00028% | 3.45% | Other |
D. E. SHAW & CO., INC. | 1,042,583 | 0.00253% | 90.61% | Other |
RENAISSANCE TECHNOLOGIES LLC | 704,600 | 0.00315% | 888.39% | Other |
ALPS ADVISORS INC | 139,250 | 0.0028% | 180.02% | Other |
AQR CAPITAL MANAGEMENT LLC | 116,489 | 0.00056% | 399.01% | Other |
TUDOR INVESTMENT CORP ET AL | 12,753 | 0.00023% | -62.1% | Event Driven, Other |
BALYASNY ASSET MANAGEMENT L.P. | 19,698 | 0.00054% | Exited | Event Driven |
CHANGE IN SHARES OUTSTANDING FOR AMYLYX PHARMACEUTICALS INC
STOCK BUYBACKS FOR AMYLYX PHARMACEUTICALS INC
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
-0.31%
1Q
06/30/2023
-0.85%
2Q
03/31/2023
-1.88%
3Q
12/31/2022
6.17%
4Q
09/30/2022
18.79%
5Q
06/30/2022
19.32%
6Q
03/31/2022
34.75%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AMYLYX PHARMACEUTICALS INC
LOADING...